iVEAcare is a development-stage medical device company based in Roseville, MN, developing an innovative neuromodulation therapy to address unmet clinical needs impacting large patient populations. It focuses on developing and commercializing technology platforms to treat patients suffering from chronic diseases. The company is led by newly appointed President and CEO Todd Kerkow and co-founder & Chairman Mudit Jain. iVEAcare is the third spin-off from NuXcel, a medical device accelerator managed by Mudit K. Jain and Lynn Elliott and backed by Treo Ventures. In April 2024 it raised $27.5M in a Series A to expand operations and development efforts. The company intends to use the funds to broaden development activities and scale operations as it advances its therapy.

Total raised

$28M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2024